최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기AIDS research and human retroviruses, v.17 no.4, 2001년, pp.295 - 309
Dern, Kirsten (Deutsches Krebsforschungszentrum Heidelberg, Heidelberg 69120, Germany.) , Rübsamen-Waigmann, Helga (Institute of Virology, Bayer AG, Wuppertal 42096, Germany.) , Unger, Ronald E. (Institute for Pathology, Johannes Gutenberg University, Mainz 55131, Germany.)
A productive infection of peripheral blood lymphocytes by HIV-1 was severely inhibited by the simultaneous infection of these cells with HIV-2. A similar reciprocal effect on HIV-2 infection was not observed. The extent of virus replication was determined by virus-specific antigen capture assays of ...
J Virol Gao F 7433 68 1994 10.1128/JVI.68.11.7433-7447.1994
Guinea-Bissau. AIDS Andreasson PA 989 7 1993
Kanki, PJ, M'Boup, S, Ricard, D, Barin, F, Denis, F, Boye, C, Sangare, L, Travers, K, Albaum, M, Marlink, R, et, al.. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science, vol.236, no.4803, 827-831.
J Virol Grez M 2161 68 1994 10.1128/JVI.68.4.2161-2168.1994
MARLINK, RICHARD G., RICARD, DOMINIQUE, M'BOUP, SOULEYMANE, KANKI, PHYLLIS J., ROMET-LEMONNE, JEAN-LOUP, N'DOYE, IBRA, DIOP, KHADY, SIMPSON, MARY ANN, GRECO, FRANK, CHOU, MIN-JI, DEGRUTTOLA, VICTOR, HSIEH, CHUNG-CHENG, BOYE, CHEIKH, BARIN, FRANCIS, DENIS, FRANÇOIS, McLANE, M.F., ESSEX, M.. Clinical, Hematologic, and Immunologic Cross-Sectional Evaluation of Individuals Exposed to Human Immunodeficiency Virus Type-2 (HIV-2). AIDS research and human retroviruses, vol.4, no.2, 137-148.
Marlink, R, Kanki, P, Thior, I, Travers, K, Eisen, G, Siby, T, Traore, I, Hsieh, CC, Dia, MC, Gueye, EH, et, al.. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science, vol.265, no.5178, 1587-1590.
Kühnel, H, von Briesen, H, Dietrich, U, Adamski, M, Mix, D, Biesert, L, Kreutz, R, Immelmann, A, Henco, K, Meichsner, C. Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.. Proceedings of the National Academy of Sciences of the United States of America, vol.86, no.7, 2383-2387.
SALMINEN, MIKA O., CARR, JEAN K., BURKE, DONALD S., McCUTCHAN, FRANCINE E.. Identification of Breakpoints in Intergenotypic Recombinants of HIV Type 1 by Bootscanning. AIDS research and human retroviruses, vol.11, no.11, 1423-1425.
J Virol Zhu T 1324 69 1995 10.1128/JVI.69.2.1324-1327.1995
J Virol Diaz RS 3273 69 1995 10.1128/JVI.69.6.3273-3281.1995
J Virol Groenink M 6175 66 1992 10.1128/JVI.66.10.6175-6180.1992
J Virol Sabino EC 6340 68 1994 10.1128/JVI.68.10.6340-6346.1994
Dletrich, Ursula, Maniar, Janak K., Rübsamen-Waigmann, Helga. The epidemiology of HIV in India. Trends in microbiology, vol.3, no.1, 17-21.
Evans, L., Odehouri, K., Moreau, J., Seto, D., Thomson-Honnebier, G., Legg, H., Barboza, A., Cheng-Mayer, C., Levy, J.. SIMULTANEOUS ISOLATION OF HIV-1 AND HIV-2 FROM AN AIDS PATIENT. The Lancet, vol.332, no.8625, 1389-1391.
Rayfield, M, De Cock, K, Heyward, W, Goldstein, L, Krebs, J, Kwok, S, Lee, S, McCormick, J, Moreau, J M, Odehouri, K. Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction.. The Journal of infectious diseases : official publication of the Infectious Diseases Society of America, vol.158, no.6, 1170-1176.
Travers, K, Mboup, S, Marlink, R, Gueye-Nidaye, A, Siby, T, Thior, I, Traore, I, Dieng-Sarr, A, Sankale, JL, Mullins, C, et, al.. Natural protection against HIV-1 infection provided by HIV-2. Science, vol.268, no.5217, 1612-1615.
Arya, S K, Gallo, R C. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.. Proceedings of the National Academy of Sciences of the United States of America, vol.93, no.9, 4486-4491.
Rappaport, J., Richardson, M.W., Klotman, P.E., Arya, S.K., Baier-Bitterlich, G.. Inhibition of HIV-1 expression by HIV-2. Journal of molecular medicine : official organ of the “Gesellschaft Deutscher Naturforscher und Ärzte.”, vol.73, no.12,
AL-HARTHI, LENA, OWAIS, MOHAMMAD, ARYA, SURESH K.. Short Communication: Molecular Inhibition of HIV Type 1 by HIV Type 2: Effectiveness in Peripheral Blood Mononuclear Cells. AIDS research and human retroviruses, vol.14, no.1, 59-64.
KISHI, MASAHIKO, TOKUNAGA, KENZO, ZHENG, YONG-HUI, BAHMANI, MIRZA KHALIL, KAKINUMA, MITSUAKI, NONOYAMA, MEIHAN, LAI, PATRICK K., IKUTA, KAZUYOSHI. Superinfection of a Defective Human Immunodeficiency Virus Type 1 Provirus-Carrying T Cell Clone withviforvpuMutants Gives Cytopathic Virus Particles by Homologous Recombination. AIDS research and human retroviruses, vol.11, no.1, 45-53.
RÜBSAMEN-WAIGMANN, H., VON BRIESEN, H., HOLMES, H., BJÖRNDAL, Å., KORBER, B., ESSER, R., RANJBAR, S., TOMLINSON, P., GALVAO-CASTRO, B., KARITA, E., SEMPALA, S., WASI, C., OSMANOV, S., FENYÖ, E.-M.. Standard Conditions of Virus Isolation Reveal Biological Variability of HIV Type 1 in Different Regions of the World. AIDS research and human retroviruses, vol.10, no.11, 1401-1408.
Am J Hygiene Reed LJ 493 27 1938
Rubsamen-Waigmann, H., Willems, W.R., Bertram, U., Briesen, H.V.. REVERSAL OF HIV-PHENOTYPE TO FULMINANT REPLICATION ON MACROPHAGES IN PERINATAL TRANSMISSION. The Lancet, vol.334, no.8672, 1155-1156.
Dietrich, Ursula, Adamski, Michalina, Kreutz, Renate, Seipp, Anja, Kühnel, Herbert, Rübsamen-Waigmann, Helga. A highly divergent HIV-2-related isolate. Nature, vol.342, no.6252, 948-950.
Rübsamen‐Waigmann, H., Becker, W. B., Helm, E. B., Brodt, R., Fischer, H., Henco, K., Brede, H. D.. Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS. Journal of medical virology, vol.19, no.4, 335-344.
Moore, John P., McKeating, Jane A., Jones, Ian M., Stephens, Paul E., Clements, Gary, Thomson, Sue, Weiss, Robin A.. Characterization of recombinant gp120 and gp160 from HIV-1 : binding to monoclonal antibodies and soluble CD4. AIDS, vol.4, no.4, 307-316.
Cancer Res Nowell PC 462 20 1960
Zack, J.A., Arrigo, S.J., Weitsman, S.R., Go, A.S., Haislip, A., Chen, I.S.Y.. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell, vol.61, no.2, 213-222.
J Virol Zack JA 1717 66 1992 10.1128/JVI.66.3.1717-1725.1992
Dalgleish, Angus G., Beverley, Peter C. L., Clapham, Paul R., Crawford, Dorothy H., Greaves, Melvyn F., Weiss, Robin A.. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, vol.312, no.5996, 763-767.
Klatzmann, David, Champagne, Eric, Chamaret, Sophie, Gruest, Jacqueline, Guetard, Denise, Hercend, Thierry, Gluckman, Jean-Claude, Montagnier, Luc. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature, vol.312, no.5996, 767-768.
Hart, A.R., Cloyd, M.W.. Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2. Virology, vol.177, no.1, 1-10.
Le Guern, M, Levy, J A. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.. Proceedings of the National Academy of Sciences of the United States of America, vol.89, no.1, 363-367.
J Virol Liu H 7630 69 1995 10.1128/JVI.69.12.7630-7638.1995
J Virol Simm M 4582 69 1995 10.1128/JVI.69.7.4582-4586.1995
J Virol Gabuzda DH 6489 66 1992 10.1128/JVI.66.11.6489-6495.1992
J Virol Sakai H 1663 67 1993 10.1128/JVI.67.3.1663-1666.1993
Simon, J H, Miller, D L, Fouchier, R A, Soares, M A, Peden, K W, Malim, M H. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission.. The EMBO journal, vol.17, no.5, 1259-1267.
J Virol Klimkait T 621 64 1990 10.1128/JVI.64.2.621-629.1990
J Virol Bouyac M 9358 71 1997 10.1128/JVI.71.12.9358-9365.1997
J Virol Callahan MA 5189 72 1998 10.1128/JVI.72.6.5189-5197.1998
J Virol Kim SY 3708 63 1989 10.1128/JVI.63.9.3708-3713.1989
※ AI-Helper는 부적절한 답변을 할 수 있습니다.